Cargando…

Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates

BACKGROUND: The development of regenerative therapy for human spinal cord injury (SCI) is dramatically restricted by two main challenges: the need for a safe source of functionally active and reproducible neural stem cells and the need of adequate animal models for preclinical testing. Direct reprog...

Descripción completa

Detalles Bibliográficos
Autores principales: Baklaushev, Vladimir P, Durov, Oleg V, Kalsin, Vladimir A, Gulaev, Eugene V, Kim, Sergey V, Gubskiy, Ilya L, Revkova, Veronika A, Samoilova, Ekaterina M, Melnikov, Pavel A, Karal-Ogly, Dzhina D, Orlov, Sergey V, Troitskiy, Alexander V, Chekhonin, Vladimir P, Averyanov, Alexander V, Ahlfors, Jan-Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176843/
https://www.ncbi.nlm.nih.gov/pubmed/34136075
http://dx.doi.org/10.4252/wjsc.v13.i5.452
_version_ 1783703314596102144
author Baklaushev, Vladimir P
Durov, Oleg V
Kalsin, Vladimir A
Gulaev, Eugene V
Kim, Sergey V
Gubskiy, Ilya L
Revkova, Veronika A
Samoilova, Ekaterina M
Melnikov, Pavel A
Karal-Ogly, Dzhina D
Orlov, Sergey V
Troitskiy, Alexander V
Chekhonin, Vladimir P
Averyanov, Alexander V
Ahlfors, Jan-Eric
author_facet Baklaushev, Vladimir P
Durov, Oleg V
Kalsin, Vladimir A
Gulaev, Eugene V
Kim, Sergey V
Gubskiy, Ilya L
Revkova, Veronika A
Samoilova, Ekaterina M
Melnikov, Pavel A
Karal-Ogly, Dzhina D
Orlov, Sergey V
Troitskiy, Alexander V
Chekhonin, Vladimir P
Averyanov, Alexander V
Ahlfors, Jan-Eric
author_sort Baklaushev, Vladimir P
collection PubMed
description BACKGROUND: The development of regenerative therapy for human spinal cord injury (SCI) is dramatically restricted by two main challenges: the need for a safe source of functionally active and reproducible neural stem cells and the need of adequate animal models for preclinical testing. Direct reprogramming of somatic cells into neuronal and glial precursors might be a promising solution to the first challenge. The use of non-human primates for preclinical studies exploring new treatment paradigms in SCI results in data with more translational relevance to human SCI. AIM: To investigate the safety and efficacy of intraspinal transplantation of directly reprogrammed neural precursor cells (drNPCs). METHODS: Seven non-human primates with verified complete thoracic SCI were divided into two groups: drNPC group (n = 4) was subjected to intraspinal transplantation of 5 million drNPCs rostral and caudal to the lesion site 2 wk post injury, and lesion control (n = 3) was injected identically with the equivalent volume of vehicle. RESULTS: Follow-up for 12 wk revealed that animals in the drNPC group demonstrated a significant recovery of the paralyzed hindlimb as well as recovery of somatosensory evoked potential and motor evoked potential of injured pathways. Magnetic resonance diffusion tensor imaging data confirmed the intraspinal transplantation of drNPCs did not adversely affect the morphology of the central nervous system or cerebrospinal fluid circulation. Subsequent immunohistochemical analysis showed that drNPCs maintained SOX2 expression characteristic of multipotency in the transplanted spinal cord for at least 12 wk, migrating to areas of axon growth cones. CONCLUSION: Our data demonstrated that drNPC transplantation was safe and contributed to improvement of spinal cord function after acute SCI, based on neurological status assessment and neurophysiological recovery within 12 wk after transplantation. The functional improvement described was not associated with neuronal differentiation of the allogeneic drNPCs. Instead, directed drNPCs migration to the areas of active growth cone formation may provide exosome and paracrine trophic support, thereby further supporting the regeneration processes.
format Online
Article
Text
id pubmed-8176843
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-81768432021-06-15 Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates Baklaushev, Vladimir P Durov, Oleg V Kalsin, Vladimir A Gulaev, Eugene V Kim, Sergey V Gubskiy, Ilya L Revkova, Veronika A Samoilova, Ekaterina M Melnikov, Pavel A Karal-Ogly, Dzhina D Orlov, Sergey V Troitskiy, Alexander V Chekhonin, Vladimir P Averyanov, Alexander V Ahlfors, Jan-Eric World J Stem Cells Basic Study BACKGROUND: The development of regenerative therapy for human spinal cord injury (SCI) is dramatically restricted by two main challenges: the need for a safe source of functionally active and reproducible neural stem cells and the need of adequate animal models for preclinical testing. Direct reprogramming of somatic cells into neuronal and glial precursors might be a promising solution to the first challenge. The use of non-human primates for preclinical studies exploring new treatment paradigms in SCI results in data with more translational relevance to human SCI. AIM: To investigate the safety and efficacy of intraspinal transplantation of directly reprogrammed neural precursor cells (drNPCs). METHODS: Seven non-human primates with verified complete thoracic SCI were divided into two groups: drNPC group (n = 4) was subjected to intraspinal transplantation of 5 million drNPCs rostral and caudal to the lesion site 2 wk post injury, and lesion control (n = 3) was injected identically with the equivalent volume of vehicle. RESULTS: Follow-up for 12 wk revealed that animals in the drNPC group demonstrated a significant recovery of the paralyzed hindlimb as well as recovery of somatosensory evoked potential and motor evoked potential of injured pathways. Magnetic resonance diffusion tensor imaging data confirmed the intraspinal transplantation of drNPCs did not adversely affect the morphology of the central nervous system or cerebrospinal fluid circulation. Subsequent immunohistochemical analysis showed that drNPCs maintained SOX2 expression characteristic of multipotency in the transplanted spinal cord for at least 12 wk, migrating to areas of axon growth cones. CONCLUSION: Our data demonstrated that drNPC transplantation was safe and contributed to improvement of spinal cord function after acute SCI, based on neurological status assessment and neurophysiological recovery within 12 wk after transplantation. The functional improvement described was not associated with neuronal differentiation of the allogeneic drNPCs. Instead, directed drNPCs migration to the areas of active growth cone formation may provide exosome and paracrine trophic support, thereby further supporting the regeneration processes. Baishideng Publishing Group Inc 2021-05-26 2021-05-26 /pmc/articles/PMC8176843/ /pubmed/34136075 http://dx.doi.org/10.4252/wjsc.v13.i5.452 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Basic Study
Baklaushev, Vladimir P
Durov, Oleg V
Kalsin, Vladimir A
Gulaev, Eugene V
Kim, Sergey V
Gubskiy, Ilya L
Revkova, Veronika A
Samoilova, Ekaterina M
Melnikov, Pavel A
Karal-Ogly, Dzhina D
Orlov, Sergey V
Troitskiy, Alexander V
Chekhonin, Vladimir P
Averyanov, Alexander V
Ahlfors, Jan-Eric
Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates
title Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates
title_full Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates
title_fullStr Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates
title_full_unstemmed Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates
title_short Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates
title_sort disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates
topic Basic Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176843/
https://www.ncbi.nlm.nih.gov/pubmed/34136075
http://dx.doi.org/10.4252/wjsc.v13.i5.452
work_keys_str_mv AT baklaushevvladimirp diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT durovolegv diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT kalsinvladimira diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT gulaeveugenev diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT kimsergeyv diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT gubskiyilyal diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT revkovaveronikaa diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT samoilovaekaterinam diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT melnikovpavela diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT karaloglydzhinad diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT orlovsergeyv diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT troitskiyalexanderv diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT chekhoninvladimirp diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT averyanovalexanderv diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates
AT ahlforsjaneric diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates